Abstract
The present study aimed to explore the biological characteristics of non-small cell lung cancer (NSCLC) cells and the mechanism of chemosensitivity through the role of the PI3K/Akt/mTOR signaling pathway mediated by BRAF gene silencing. Following cell transfection and grouping, an MTT assay detected the activity of NSCLC cells, a scratch wound test assessed the migration ability, flow cytometry using PI staining detected the cell cycle phase, TUNEL and flow cytometry through Annexin V-PI staining assessed the apoptosis, and colony formation was used to detect the sensitivity of lung cancer cells to cisplatin chemotherapy. Furthermore, the relative expression levels of BRAF, PTEN, PI3K, mTOR mRNA were assessed by RT-qPCR, and the protein expression levels of BRAF, PTEN, PI3K, phosphorylated (p)-PI3K, Akt, p-Akt, mTOR, p-mTOR, cisplatin resistance-related enzymes ERCC1 and BRCA1, apoptotic proteins Bax and Bcl-2 were assessed by western blotting. Compared with the control group and NC group, there were differences in decreased BRAF mRNA expression levels in the small interfering (si)BRAF group and siBRAF + IGF-1 group (both P<0.05). In addition, compared with the control group, the siBRAF, NVP-BEZ235 and siBRAF + NVP-BEZ235 group...Continue Reading
References
Feb 16, 2002·Methods : a Companion to Methods in Enzymology·K J Livak, T D Schmittgen
Jun 23, 2009·European Journal of Obstetrics, Gynecology, and Reproductive Biology·Hai-Yan ZhangHong Sun
Mar 25, 2011·BMB Reports·Sung Ho AnMyeong Seon Lee
May 29, 2012·Asian Pacific Journal of Cancer Prevention : APJCP·Jia-Li XuYong-Qian Shu
Jul 10, 2012·Proceedings of the National Academy of Sciences of the United States of America·Kadoaki OhashiWilliam Pao
Aug 30, 2012·Journal of Cellular Biochemistry·Jiezhong ChenYin Xiao
Feb 5, 2013·Cancer Chemotherapy and Pharmacology·Howard A Burris
Oct 25, 2014·Lung Cancer Management·Haiying ChengRoman Perez-Soler
Dec 24, 2014·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Chong XuXiaobo Sun
Oct 1, 2015·Oncotarget·Gillian FarnieMichael P Lisanti
Dec 15, 2015·Oncotarget·Hongyu LiBingliang Fang
Jan 19, 2017·Oncotarget·Elke NolteXin Lai
Mar 6, 2017·Oncology Reports·Weiwei WangShaojia Wang
Mar 14, 2017·Journal of Drug Targeting·Binqiang TianYonghui Li
Apr 21, 2017·Cold Spring Harbor Symposia on Quantitative Biology·Madeleine J Oudin, Valerie M Weaver
Apr 22, 2017·Oncotarget·Arlene L OeiNicolaas A P Franken
May 6, 2017·Journal of Cellular Biochemistry·Afsane BahramiAmir Avan
May 11, 2017·European Journal of Cancer Care·E K MaselM Preusser
Jul 1, 2017·Evidence-based Complementary and Alternative Medicine : ECAM·Zheng GuoyinLing Changquan
Jul 12, 2017·The Biochemical Journal·Chunyang DuYunzhuo Ren
Sep 3, 2017·Bioscience Reports·Weirong XiaoXiaopeng Xu
Sep 9, 2017·Oncotarget·Liyong ZhangLan Ko
Oct 17, 2017·Nature Communications·Alexandros GlentisDanijela Matic Vignjevic
Oct 28, 2017·Indian Journal of Hematology & Blood Transfusion : an Official Journal of Indian Society of Hematology and Blood Transfusion·Miao LiuYi Jiang
Dec 7, 2017·The International Journal of Biochemistry & Cell Biology·Hao WangJinshan Zhang
Jan 6, 2018·Journal of Cancer Prevention·Gi Dae Kim
Feb 6, 2018·The Annals of Thoracic Surgery·Anne-Claire ToffartDenis Moro-Sibilot
Feb 25, 2018·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Antonin LevyUNKNOWN Young Investigators EORTC Lung Cancer Group (YI EORTC LCG)
Mar 7, 2018·Oncotarget·Keigo OkadaOsamu Miura
Mar 9, 2018·Journal of Medical Economics·Anand A DalalKenneth W Culver
Mar 24, 2018·Oncotarget·Paula L FarréAdriana De Siervi
Jul 25, 2018·Oncotarget·Vino T CheriyanArun K Rishi
Nov 18, 2018·Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·M MajemM Provencio